Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue (2018)
- Authors:
- USP affiliated authors: SEELAENDER, MARILIA CERQUEIRA LEITE - ICB ; ROSA NETO, JOSÉ CESAR - ICB
- Unidade: ICB
- DOI: 10.3389/fphar.2018.00452
- Subjects: TECIDO ADIPOSO; METFORMINA; GLICOSE; QUIMIOTERAPIA; CAMUNDONGOS; INSULINA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 9, p. 1-10, 2018
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
BIONDO, Luana A. et al. Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue. Frontiers in Pharmacology, v. 9, p. 1-10, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00452. Acesso em: 01 abr. 2026. -
APA
Biondo, L. A., Batatinha, H. A., Souza, C. O. de, Teixeira, A. A. de S., Silveira, L. S., Alonso-Vale, M. I., et al. (2018). Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue. Frontiers in Pharmacology, 9, 1-10. doi:10.3389/fphar.2018.00452 -
NLM
Biondo LA, Batatinha HA, Souza CO de, Teixeira AA de S, Silveira LS, Alonso-Vale MI, Oyama LM, Alves MJ, Seelaender MCL, Rosa Neto JC. Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-10.[citado 2026 abr. 01 ] Available from: https://doi.org/10.3389/fphar.2018.00452 -
Vancouver
Biondo LA, Batatinha HA, Souza CO de, Teixeira AA de S, Silveira LS, Alonso-Vale MI, Oyama LM, Alves MJ, Seelaender MCL, Rosa Neto JC. Metformin mitigates fibrosis and glucose intolerance induced by doxorubicin in subcutaneous adipose tissue [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-10.[citado 2026 abr. 01 ] Available from: https://doi.org/10.3389/fphar.2018.00452 - The therapeutic potential of exercise to treat cachexia
- Costly immunometabolic remodeling in disused muscle buildup through physical exercise
- Inflammation in the disease: Mechanism and therapies 2014
- Modulatory effects of physical activity levels on immune responses and general clinical functions in adult patients with mild to moderate SARS-CoV-2 infections—a protocol for an observational prospective follow-Up investigation: Fit-COVID-19 Study
- Mild to moderate post-COVID-19 alters markers of lymphocyte activation, exhaustion, and immunometabolic responses that can be partially associated by physical activity level- an observational sub-analysis fit- COVID study
- Importância dos efeitos fisiológicos do exercício na promoção da saúde
- Aerobic Exercise Modulates the Free Fatty Acids and Inflammatory Response During Obesity and Cancer Cachexia
- Aerobic exercise, but not metformin, prevents reduction of muscular performance by AMPk activation in mice on doxorubicin chemotherapy
- Hypothalamic energy metabolism is impaired by doxorubicin independently of inflammation in non-tumour-bearing rats
- Immunometabolic responses according to physical fitness status and lifelong exercise during aging: new roads for exercise immunology
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
